Maplight Therapeutics

This study looks at the safety of a drug called ML-004 in 120 teens and adults with autism who have already taken it in a previous study. Participants will take the drug for a longer time so doctors can watch for side effects. The goal is not to cure autism but to see if the drug…

This study tests an investigational drug called ML-004 to see if it can help improve social communication in adolescents and adults with autism spectrum disorder. About 150 participants aged 12 to 45 will receive either ML-004 or a placebo for a set period. The main goal is to me…